- Член од
- 13 јули 2006
- Мислења
- 15.573
- Поени од реакции
- 18.607
Ги следеле 8 дена?Researchers reviewed data from 728,321 individuals aged 12 or above who had received the third dose of the BNT162b2 vaccine. These individuals were carefully matched 1:1 with 728,321 individuals who had received only two shots of the BNT162b2 vaccine at least five months prior.![]()
Largest real-world study of third dose of COVID-19 vaccine effectiveness shows Delta resistance
The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world's largest integrated health record databases to examine the effectiveness of the third dose of the Pfizer/BioNTech BNT162B2 vaccine against the Delta variant of SARS-CoV-2. The...www.google.com
The study included a total of over 12,000,000 person-days of follow-up.
The results show that, compared with individuals who received only two doses five months prior, individuals who received three doses of the vaccine (7 days or more after the third dose) had 93% lower risk of COVID-19-related hospitalization, 92% lower risk of severe COVID-19 disease, and 81% lower risk of COVID-19-related death. Vaccine effectiveness was found to be similar for different sexes, age groups (ages 40-69 and 70+) and number of comorbidities.
Неверојатно какви глупости се преставуваат како студии.
Покажуваат колку е неефикасна вакцината по 5 месеци и заговараат 3 доза од исто таква неефикасна вакцина.
Во кои гомна е наукава, тоа е неверојатно.